Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Executive Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
Fragile X Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Scientific Presentations
Publications
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
Analyst Coverage
22-Sep-2022
View Update Report: MST Access 27 September 2022
27-Jul-2022
View Update Report: MST Access 27 July 2022
18-Jul-2022
View Update Report: MST Access 18 July 2022
30-Mar-2022
View Update Report: MST Access 30 March 2022
14-Feb-2022
View Update Report: MST Access 14 February 2022
12-Nov-2021
View Update Report 12 November 2021
22-Sep-2021
View Extract - Edition 902 22 September 2021
8-Sep-2021
View Extract - Edition 901 8 September 2021
11-Aug-2021
View Update Report 11 August 2021
11-Aug-2021
View Extract - Edition 899 11 August 2021
15-Jun-2021
View Extract - Edition 895 15 June 2021
19-Apr-2021
View Extract - Edition 888 19 April 2021
18-Feb-2021
View Update Report 18 Feb 2021
16-Feb-2021
View Update Report 16 Feb 2021
5-Nov-2020
View Update Report 5 November 2020
28-May-2020
View Update Report 28 May 2020
14-Nov-2019
View Initiation Report 14 November 2019